Medical Research
(H43)
990 on File
INTERNATIONAL ANDREAS GRUENTZIG SOCIETY
Financial strength (30%)
86/100
Reliability (20%)
55/100
Effectiveness (25%)
78/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$1.1M
Total Revenue
$1.0M
Total Expenses
$439K
Net Assets
0
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
91.0%
Fundraising Efficiency
N/A
Operating Reserve
5.11x
Liability-to-Asset
0.0%
Revenue Diversification
67.8%
Compared with Peers
FY 2025
Compared with 132 similar organizations
(United States, Medical Research, $1M–$10M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
91.0% | 83.0% |
P10P90
|
Top quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
9.1% | 9.9% |
P10P90
|
Above median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
0.0% | 2.6% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
5.1 mo | 14.4 mo |
P10P90
|
Bottom quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.0% | 13.2% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
67.8% | 90.0% |
P10P90
|
Top quarter |
|
Surplus margin
Surplus as a share of revenue
|
9.7% | 4.8% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $1.1M | $1.0M | $439K | 91.0% | 0 |
| 2023 | $473K | $310K | $286K | 82.8% | 0 |
| 2022 | $145K | $317K | $122K | 87.2% | 0 |
| 2021 | $376K | $218K | N/A | — | 0 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.